Results 301 to 310 of about 228,949 (361)
Some of the next articles are maybe not open access.

Multimodal Therapy

2019
Arnold Lazarus pioneered cognitive-behavior therapy but soon realized that it contained significant treatment omissions. He thus created multimodal therapy (MMT), a comprehensive, biopsychosocial approach to psychological assessment and technically eclectic psychotherapy.
Clifford N. Lazarus, Arnold A. Lazarus
openaire   +1 more source

Multimodality Therapy for NSCLC

2016
The standard therapy for patients with unrespectable stage III non-small-cell lung cancer (NSCLC) is the combination of chemotherapy and radiotherapy. Although the concurrent use of both treatment modalities has been shown to be superior to sequential therapy, the role for additional chemotherapy, either as induction or as consolidation, remains ...
Lingling, Du   +2 more
openaire   +2 more sources

Multimodality therapy for Pancoast tumor

Nature Clinical Practice Oncology, 2006
The management of Pancoast tumors has challenged surgeons and radiation and medical oncologists over several decades. Retrospective studies have raised a greater awareness of the importance of positive N2 lymph nodes in terms of prognosis and treatment decision making. While patients with positive N2 lymph nodes have generally been excluded from trials
Samir, Narayan, Charles R, Thomas
openaire   +2 more sources

COMPLICATIONS OF MULTIMODALITY THERAPY

Chest Surgery Clinics of North America, 1998
Multimodality therapy may further increase treatment-related complications. However, such therapy may be necessary for advanced or biologically aggressive tumors, and information gained from patient entry into prospective trials may attenuate current and future treatment-related complications.
openaire   +2 more sources

Multimodality Therapy for Pancreatic Cancer

Gastroenterology Clinics of North America, 2007
Neoadjuvant chemoradiotherapy can be administered safely to patients with pancreatic cancer. Complete pathologic responses are rare, however, and the benefits of this approach compared with standard adjuvant therapy are uncertain. The only way to evaluate the efficacy of neoadjuvant chemoradiotherapy is a prospective trial involving a uniform patient ...
Jan, Franko   +4 more
openaire   +2 more sources

Multimodality therapy for esophageal cancer

Surgical Clinics of North America, 2002
Esophageal cancer is undergoing a major shift in its epidemiology. Its incidence is dramatically growing and it more commonly affects younger and healthier patients. Based on the published data, there is no strong evidence to recommend routine preoperative chemotherapy for the treatment of surgically resectable esophageal carcinoma.
Yael, Refaely, Mark J, Krasna
openaire   +2 more sources

Multimodal therapy in perioperative analgesia

Best Practice & Research Clinical Anaesthesiology, 2014
This article reviews the current evidence for multimodal analgesic options for common surgical procedures. As perioperative physicians, we have come a long way from using only opioids for postoperative pain to combinations of acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), selective Cyclo-oxygenase (COX-2) inhibitors, local anesthetics, N-
Karina, Gritsenko   +4 more
openaire   +2 more sources

Selecting multimodal therapy for rhabdomyosarcoma

Expert Review of Anticancer Therapy, 2010
Rhabdomyosarcoma is a typical tumor of childhood, characterized by a high grade of malignancy, local invasiveness and a marked propensity to metastasize, but also a generally good response to chemotherapy and radiotherapy. Multimodal therapy is essential to cure rhabdomyosarcoma patients, but different uses of surgery, radiotherapy and chemotherapy ...
Sultan I, Ferrari A
openaire   +3 more sources

Combination – Multimodal Therapy

2009
Multimodal therapy includes a combination of endoscopic techniques with background proton pump inhibitor therapy. Endoscopic resection allows direct staging of neoplasia and removal of visible mucosal irregularities. Ablation of the residual Barrett’s epithelium can be accomplished by a number of thermal techniques.
Oliver Pech   +2 more
openaire   +1 more source

Multimodality Therapy of Esophageal Cancer

Chest, 1999
Multimodality therapy of esophageal cancer has been evaluated in several clinical trials, with positive results in terms of improved survival compared with single-modality therapy. A case report is presented describing the use of paclitaxel in a multimodality regimen for a patient with a bulky esophageal tumor.
openaire   +2 more sources

Home - About - Disclaimer - Privacy